CD79A and neoplasm: In line, in vivo inhibition of IgA signaling decreased the number of tumor-infiltrating IgA+PD-L1high macrophages and increased the infiltration of CD69+CD8+ T cells, eventually leading to anti-tumoral effects in a Cell-Derived tumor Xenograft (CDX, Hepa 1-6 cells) model.